<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="71">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03105934</url>
  </required_header>
  <id_info>
    <org_study_id>IVUS</org_study_id>
    <nct_id>NCT03105934</nct_id>
  </id_info>
  <brief_title>Repeatability of OCT and IV-US in Pulmonary Arterial Hypertension</brief_title>
  <official_title>Repeatability of Optical Coherence Tomography (OCT) and Intravascular Ultrasound (IV-US) in Pulmonary Arterial Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari Vall d'Hebron Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitari Vall d'Hebron Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the correlation between pulmonary IV-OCT and pulmonary IV-US measurements and
      standard PAH clinical measures of disease progression and the relative sensitivity of the
      techniques to change.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2016</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Image measurements</measure>
    <time_frame>12 months</time_frame>
    <description>Repeat acquisitions to be made in the same regions and in locations</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Pulmonary Arterial Hypertension</condition>
  <arm_group>
    <arm_group_label>Pulmonary Arterial Hypertension</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with Pulmonary Arterial Hypertension</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Patients with Pulmonary Arterial Hypertension</intervention_name>
    <description>2 repeated measurement session to enable assessment of technical and medium-term reproducibility of IV-US and IV-OCT.</description>
    <arm_group_label>Pulmonary Arterial Hypertension</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  With confirmed diagnosis of PAH Group 1 according to the ESC/ERS Guidelines

          -  With severe disease, defined as Class II- III of the modified WHO functional classes
             in the ESC/ERS Guidelines

        Exclusion Criteria:

          -  That according to investigator criteria cannot participate in the trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Enric Domingo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Vall d'Hebron</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Enric Domingo, MD</last_name>
    <phone>34 93 489 30 00</phone>
    <email>enrdomin@vhebron.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Enric Domingo, MD</last_name>
      <phone>34 93 489 30 00</phone>
      <email>enrdomin@vhebron.net</email>
    </contact>
    <contact_backup>
      <last_name>Antonio Roman, MD</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <lastchanged_date>April 4, 2017</lastchanged_date>
  <firstreceived_date>April 4, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
